Options
Targeting the nicotinic acetylcholine receptors (nAChRs) in astrocytes as a potential therapeutic target in Parkinson’s disease
Fecha de emisión
2016
Autor(es)
Jurado-Coronel J.C.
Ávila-Rodriguez M.
Capani F.
Gonzalez J.
Morán V.E.
DOI
10.2174/138161282210160304112133
Temas
Apoptosis
Astrocytes
nAChRs
Neuroinflammation
Neuroprotection
Nicotine
Parkinson disease
nicotine
nicotinic receptor
neuroprotective agent...
nicotinic receptor
apoptosis
Article
astrocyte
cell activation
cognitive defect
disability
disease course
dopaminergic nerve ce...
drug mechanism
gait disorder
glia cell
human
immune response
in vitro study
in vivo study
muscle rigidity
nerve cell plasticity...
nervous system inflam...
neuroprotection
nonhuman
Parkinson disease
priority journal
protein expression
protein targeting
quality of life
substantia nigra pars...
tremor
animal
astrocyte
chemistry
drug effects
metabolism
Parkinson disease
pathology
Animals
Astrocytes
Humans
Neuroprotective Agent...
Parkinson Disease
Receptors, Nicotinic
Archivo(s)